Patient-derived colorectal cancer organoids were generated and cultured as described earlier [21 (
link), 22 (
link)]. In brief, the tissue was cut into small pieces and dissociated at 37 °C. Dissociated cells were passed through a 30 and 100 μm cell strainer and collected in
advanced DMEM/F12 medium (Thermo Fisher Scientific GmbH, Waltham, Massachusetts, US) supplemented with
Glutamax (Thermo Fisher Scientific GmbH, Waltham, Massachusetts, US),
penicillin/streptomycin,
HEPES,
N-acetylcysteine (Merck Chemicals GmbH, Darmstadt, Germany),
N-2 supplement (Thermo Fisher Scientific GmbH, Waltham, Massachusetts, US),
B-27 supplement (Thermo Fisher Scientific GmbH, Waltham, Massachusetts, US), EGF (PeproTech GmbH, Hamburg, Germany), Y27632 (Absource Diagnostics GmbH, Munich, Germany), and
amphotericin (Sigma-Aldrich Chemical, St. Louis, Missouri, US) and embedded in
matrigel (Corning B.V., Amsterdam, Netherlands). For subcultivation, organoids were removed from
matrigel and dissociated into small organoids using
TrypLE (Thermo Fisher Scientific GmbH, Waltham, Massachusetts, US) and then transferred into fresh
matrigel. For coculture experiments, organoids were dissociated into small organoids and 2,500–5,000 small organoids were seeded onto the peritoneum.
Mönch D., Koch J., Maaß A., Janssen N., Mürdter T., Renner P., Fallier-Becker P., Solaß W., Schwab M., Dahlke M.H., Schlitt H.J, & Leibold T. (2021). A human ex vivo coculture model to investigate peritoneal metastasis and innovative treatment options. Pleura and Peritoneum, 6(3), 121-129.